The effects of bone therapy on tibial bone loss in young women with anorexia nervosa

24Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: Osteoporosis is recognized as a common medical complication of anorexia nervosa (AN). The purpose of the current study was to investigate the recovery mechanism of osteoporosis in AN and the effect of medical treatment on the skeletal system. Method: We conducted a randomized placebo-controlled study of the effects of etidronate and calcium and vitamin D on bone loss in 41 outpatients with the restricting type of AN (AN-R). We measured the tibia I speed of sound (SOS) before and after 3 months of treatment. Results: The bone mineral density (BMD) of the tibial SOS change in both the etidronate group and the calcium and vitamin D Group was significantly greater (p < .001) than in the control group. Urine-N-telopeptide cross-links of type I collagen (NTx) before and after treatment decreased significantly (p < .01) in the etidronate group. Conclusion: These findings suggest that both etidronate and calcium and vitamin D are equally efficacious for reversing the degree of osteoporosis in patients with AN. © 2005 by Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Nakahara, T., Nagai, N., Tanaka, M., Muranaga, T., Kojima, S., Nozoe, S. I., & Naruo, T. (2006). The effects of bone therapy on tibial bone loss in young women with anorexia nervosa. International Journal of Eating Disorders, 39(1), 20–26. https://doi.org/10.1002/eat.20197

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free